MedTrace Logo

Early Use of Opioid in Radiation Mucositis

NCT02309437 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-07-17

No results posted yet for this study

Summary

This study is a superiority research to evaluate the safety and effectiveness of early use of oxycodone control release tablet for radiation mucositis in nasopharyngeal carcinoma patients.

Conditions

  • Nutrition Disorders
  • Quality of Life

Interventions

DRUG

Oxycodone

Use oxycodone to treat patients with mild pain caused by radiation mucositis.

DRUG

Oxycodone

Use oxycodone to treat patients with moderate/severe pain caused by radiation mucositis.

Sponsors & Collaborators

  • Affiliated Cancer Hospital & Institute of Guangzhou Medical University

    lead OTHER

Principal Investigators

  • Dong-ping Chen, M. D. · Affiliated Cancer Hospital & Institute of Guangzhou Medical University

  • Bin Qi, M. D. · Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02309437 on ClinicalTrials.gov